COMPARATIVE ANALYSIS OF PULMONARY HYPERTENSION IN THE 105 CML PATIENTS TREATED WITH IMATINIB, NILOTINIB AND DASATINIB

被引：0
|
作者：
Minami, M. [1 ]
Miyamoto, T. [1 ]
Akashi, K. [1 ]
机构：
[1] Kyushu Univ, Dept Med & Biosyst Sci, Fukuoka, Japan
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB1816
引用
收藏
页码：728 / 728
页数：1
相关论文
共 50 条
  • [1] Comparative analysis of pulmonary hypertension in patients treated with imatinib, nilotinib and dasatinib
    Minami, Mariko
    Arita, Takeshi
    Iwasaki, Hiromi
    Muta, Tsuyoshi
    Aoki, Takatoshi
    Aoki, Kenichi
    Yamasaki, Satoshi
    Matsushima, Takamitsu
    Kato, Koji
    Takenaka, Katsuto
    Tanimoto, Kazuki
    Kamimura, Tomohiko
    Ogawa, Ryosuke
    Akashi, Koichi
    Miyamoto, Toshihiro
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (04) : 578 - 587
  • [2] Comparative Analysis of Tyrosine Kinase Inhibitors-Related Pulmonary Hypertension in the Patients Treated By Imatinib, Dasatinib and Nilotinib
    Minami, Mariko
    Miyamoto, Toshihiro
    Arita, Takeshi
    Kamimura, Tomohiko
    Yuda, Junichiro
    Kikushige, Yoshikane
    Mori, Yasuo
    Yoshimoto, Goichi
    Kamezaki, Kenjiro
    Kato, Koji
    Shiratsuchi, Motoaki
    Takenaka, Katsuto
    Iwasaki, Hiromi
    Yamasaki, Satoshi
    Muta, Tsuyoshi
    Tanimoto, Kazuki
    Ogawa, Ryosuke
    Eto, Tetsuya
    Akashi, Koichi
    BLOOD, 2015, 126 (23)
  • [3] Dynamics of the emergence of dasatinib and nilotinib resistance in imatinib-resistant CML patients
    Gruber, F. X.
    Ernst, T.
    Porkka, K.
    Engh, R. A.
    Mikkola, I.
    Maier, J.
    Lange, T.
    Hochhaus, A.
    LEUKEMIA, 2012, 26 (01) : 172 - 177
  • [4] Dynamics of the emergence of dasatinib and nilotinib resistance in imatinib-resistant CML patients
    F X Gruber
    T Ernst
    K Porkka
    R A Engh
    I Mikkola
    J Maier
    T Lange
    A Hochhaus
    Leukemia, 2012, 26 : 172 - 177
  • [5] Immunoprofile of Patients with Chronic Myeloid Leukemia Treated with Imatinib, Nilotinib or Dasatinib
    Hayashi, Yoshiki
    Nakamae, Hirohisa
    Katayama, Takako
    Nakane, Takahiko
    Koh, Hideo
    Nishimoto, Mitsutaka
    Nakamae, Mika
    Yoshida, Masahiro
    Bingo, Masato
    Okamura, Hiroshi
    Aimoto, Mizuki
    Manabe, Masahiro
    Yoshimura, Takuro
    Inaba, Akiko
    Nanno, Satoshi
    Hagihara, Kiyoyuki
    Nakao, Yoshitaka
    Terada, Yoshiki
    Hino, Masayuki
    BLOOD, 2011, 118 (21) : 1607 - 1607
  • [6] Dasatinib and nilotinib: effective alternatives to imatinib in CML and Ph-ALL?
    Nature Clinical Practice Oncology, 2006, 3 (10): : 526 - 526
  • [7] NICE guidance on dasatinib, high-dose imatinib, and nilotinib for patients with CML who are resistant or intolerant to imatinib
    Goulden, Scott
    Sutcliffe, Frances
    Stevens, Andrew
    LANCET ONCOLOGY, 2012, 13 (02): : 127 - 128
  • [8] PREDICTIVE FACTORS OF STABLE DEEP MOLECULAR RESPONSE IN CHRONIC PHASE CML PATIENTS TREATED WITH DASATINIB OR NILOTINIB AFTER IMATINIB FAILURE
    Bonifacio, M.
    Binotto, G.
    Tiribelli, M.
    Scaffidi, L.
    Iurlo, A.
    Cibien, F.
    Maino, E.
    Guella, A.
    Festini, G.
    Minotto, C.
    De Biasi, E.
    Frison, L.
    De Marchi, F.
    Medeot, M.
    Bucelli, C.
    Calistri, E.
    Stulle, M.
    Gherlinzoni, F.
    Cortelezzi, A.
    Fanin, R.
    Semenzato, G.
    Krampera, M.
    Pizzolo, G.
    Ambrosetti, A.
    HAEMATOLOGICA, 2016, 101 : 735 - 735
  • [9] Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib
    Hayashi, Yoshiki
    Nakamae, Hirohisa
    Katayama, Takako
    Nakane, Takahiko
    Koh, Hideo
    Nakamae, Mika
    Hirose, Asao
    Hagihara, Kiyoyuki
    Terada, Yoshiki
    Nakao, Yoshitaka
    Hino, Masayuki
    LEUKEMIA & LYMPHOMA, 2012, 53 (06) : 1084 - 1089
  • [10] Hypercholesterolemia In Imatinib Intolerant/Resistant CML-CP Patients Treated With Nilotinib: A Retrospective Analysis
    Hiwase, Devendra K.
    Yeung, David T.
    Carne, Lisa
    Ross, David
    Grigg, Andrew
    Hughes, Timothy P.
    BLOOD, 2013, 122 (21)
12345